nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—ABCC10—Cytarabine—lymphatic system cancer	0.157	0.197	CbGbCtD
Cyclosporine—ABCC10—Vincristine—lymphatic system cancer	0.0745	0.0936	CbGbCtD
Cyclosporine—ABCC3—Vincristine—lymphatic system cancer	0.0469	0.0589	CbGbCtD
Cyclosporine—ABCC10—Methotrexate—lymphatic system cancer	0.0451	0.0567	CbGbCtD
Cyclosporine—ABCC1—Mitoxantrone—lymphatic system cancer	0.0418	0.0525	CbGbCtD
Cyclosporine—ABCB11—Vincristine—lymphatic system cancer	0.0405	0.0509	CbGbCtD
Cyclosporine—ABCG2—Teniposide—lymphatic system cancer	0.04	0.0502	CbGbCtD
Cyclosporine—ABCC1—Vincristine—lymphatic system cancer	0.0288	0.0361	CbGbCtD
Cyclosporine—ABCC3—Methotrexate—lymphatic system cancer	0.0284	0.0356	CbGbCtD
Cyclosporine—ABCG2—Mitoxantrone—lymphatic system cancer	0.028	0.0351	CbGbCtD
Cyclosporine—CYP3A5—Teniposide—lymphatic system cancer	0.0222	0.0278	CbGbCtD
Cyclosporine—ABCC2—Vincristine—lymphatic system cancer	0.0213	0.0267	CbGbCtD
Cyclosporine—ABCG2—Vincristine—lymphatic system cancer	0.0193	0.0242	CbGbCtD
Cyclosporine—CYP2C19—Teniposide—lymphatic system cancer	0.0179	0.0225	CbGbCtD
Cyclosporine—ABCC1—Methotrexate—lymphatic system cancer	0.0174	0.0219	CbGbCtD
Cyclosporine—SLCO1A2—Methotrexate—lymphatic system cancer	0.0156	0.0195	CbGbCtD
Cyclosporine—CYP2C9—Teniposide—lymphatic system cancer	0.0149	0.0187	CbGbCtD
Cyclosporine—SLCO1B1—Methotrexate—lymphatic system cancer	0.0147	0.0184	CbGbCtD
Cyclosporine—CYP3A7—Vincristine—lymphatic system cancer	0.0142	0.0179	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0142	0.0179	CbGbCtD
Cyclosporine—ABCC2—Methotrexate—lymphatic system cancer	0.0129	0.0162	CbGbCtD
Cyclosporine—ABCG2—Methotrexate—lymphatic system cancer	0.0117	0.0146	CbGbCtD
Cyclosporine—CYP3A5—Vincristine—lymphatic system cancer	0.0107	0.0134	CbGbCtD
Cyclosporine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0101	0.0127	CbGbCtD
Cyclosporine—SLC22A6—Methotrexate—lymphatic system cancer	0.00943	0.0118	CbGbCtD
Cyclosporine—CYP3A4—Cytarabine—lymphatic system cancer	0.00877	0.011	CbGbCtD
Cyclosporine—CYP3A4—Teniposide—lymphatic system cancer	0.00864	0.0109	CbGbCtD
Cyclosporine—ABCB1—Vincristine—lymphatic system cancer	0.00694	0.00872	CbGbCtD
Cyclosporine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.00604	0.00759	CbGbCtD
Cyclosporine—ABCB1—Methotrexate—lymphatic system cancer	0.0042	0.00528	CbGbCtD
Cyclosporine—CYP3A4—Vincristine—lymphatic system cancer	0.00416	0.00522	CbGbCtD
Cyclosporine—Diarrhoea—Teniposide—lymphatic system cancer	0.000195	0.000955	CcSEcCtD
Cyclosporine—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000194	0.000951	CcSEcCtD
Cyclosporine—Myalgia—Bleomycin—lymphatic system cancer	0.000191	0.000938	CcSEcCtD
Cyclosporine—Chest pain—Bleomycin—lymphatic system cancer	0.000191	0.000938	CcSEcCtD
Cyclosporine—Alopecia—Vincristine—lymphatic system cancer	0.00019	0.000932	CcSEcCtD
Cyclosporine—Coma—Methotrexate—lymphatic system cancer	0.00019	0.000931	CcSEcCtD
Cyclosporine—Discomfort—Bleomycin—lymphatic system cancer	0.000189	0.000927	CcSEcCtD
Cyclosporine—Mental disorder—Vincristine—lymphatic system cancer	0.000188	0.000924	CcSEcCtD
Cyclosporine—Chills—Mitoxantrone—lymphatic system cancer	0.000188	0.000922	CcSEcCtD
Cyclosporine—Urine output increased—Methotrexate—lymphatic system cancer	0.000188	0.000921	CcSEcCtD
Cyclosporine—Neoplasm—Methotrexate—lymphatic system cancer	0.000188	0.000921	CcSEcCtD
Cyclosporine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000187	0.000918	CcSEcCtD
Cyclosporine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000186	0.000912	CcSEcCtD
Cyclosporine—Alopecia—Mitoxantrone—lymphatic system cancer	0.000185	0.000908	CcSEcCtD
Cyclosporine—Confusional state—Bleomycin—lymphatic system cancer	0.000185	0.000907	CcSEcCtD
Cyclosporine—Vision blurred—Carmustine—lymphatic system cancer	0.000185	0.000906	CcSEcCtD
Cyclosporine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000184	0.000904	CcSEcCtD
Cyclosporine—Tremor—Carmustine—lymphatic system cancer	0.000184	0.000901	CcSEcCtD
Cyclosporine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000183	0.000899	CcSEcCtD
Cyclosporine—Oedema—Bleomycin—lymphatic system cancer	0.000183	0.000899	CcSEcCtD
Cyclosporine—Infection—Bleomycin—lymphatic system cancer	0.000182	0.000893	CcSEcCtD
Cyclosporine—Anaemia—Carmustine—lymphatic system cancer	0.000181	0.000889	CcSEcCtD
Cyclosporine—Vomiting—Teniposide—lymphatic system cancer	0.000181	0.000887	CcSEcCtD
Cyclosporine—Sepsis—Methotrexate—lymphatic system cancer	0.00018	0.000884	CcSEcCtD
Cyclosporine—Agitation—Carmustine—lymphatic system cancer	0.00018	0.000884	CcSEcCtD
Cyclosporine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00018	0.00088	CcSEcCtD
Cyclosporine—Asthenia—Fludarabine—lymphatic system cancer	0.000179	0.00088	CcSEcCtD
Cyclosporine—Rash—Teniposide—lymphatic system cancer	0.000179	0.00088	CcSEcCtD
Cyclosporine—Dermatitis—Teniposide—lymphatic system cancer	0.000179	0.000879	CcSEcCtD
Cyclosporine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000179	0.000876	CcSEcCtD
Cyclosporine—Headache—Teniposide—lymphatic system cancer	0.000178	0.000874	CcSEcCtD
Cyclosporine—Pruritus—Fludarabine—lymphatic system cancer	0.000177	0.000868	CcSEcCtD
Cyclosporine—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000177	0.000867	CcSEcCtD
Cyclosporine—Leukopenia—Carmustine—lymphatic system cancer	0.000176	0.000861	CcSEcCtD
Cyclosporine—Anorexia—Bleomycin—lymphatic system cancer	0.000175	0.000857	CcSEcCtD
Cyclosporine—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000173	0.00085	CcSEcCtD
Cyclosporine—Anaemia—Vincristine—lymphatic system cancer	0.000173	0.000849	CcSEcCtD
Cyclosporine—Agitation—Vincristine—lymphatic system cancer	0.000172	0.000844	CcSEcCtD
Cyclosporine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000172	0.000843	CcSEcCtD
Cyclosporine—Polyuria—Methotrexate—lymphatic system cancer	0.000172	0.000842	CcSEcCtD
Cyclosporine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000171	0.000839	CcSEcCtD
Cyclosporine—Convulsion—Carmustine—lymphatic system cancer	0.00017	0.000833	CcSEcCtD
Cyclosporine—Hypertension—Carmustine—lymphatic system cancer	0.000169	0.00083	CcSEcCtD
Cyclosporine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000169	0.00083	CcSEcCtD
Cyclosporine—Nausea—Teniposide—lymphatic system cancer	0.000169	0.000829	CcSEcCtD
Cyclosporine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000168	0.000826	CcSEcCtD
Cyclosporine—Vertigo—Vincristine—lymphatic system cancer	0.000168	0.000825	CcSEcCtD
Cyclosporine—Hepatic failure—Methotrexate—lymphatic system cancer	0.000168	0.000823	CcSEcCtD
Cyclosporine—Leukopenia—Vincristine—lymphatic system cancer	0.000168	0.000822	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000167	0.000819	CcSEcCtD
Cyclosporine—Chest pain—Carmustine—lymphatic system cancer	0.000167	0.000819	CcSEcCtD
Cyclosporine—Myalgia—Carmustine—lymphatic system cancer	0.000167	0.000819	CcSEcCtD
Cyclosporine—Anxiety—Carmustine—lymphatic system cancer	0.000166	0.000816	CcSEcCtD
Cyclosporine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000165	0.000807	CcSEcCtD
Cyclosporine—Malaise—Mitoxantrone—lymphatic system cancer	0.000164	0.000806	CcSEcCtD
Cyclosporine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000163	0.000802	CcSEcCtD
Cyclosporine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000163	0.0008	CcSEcCtD
Cyclosporine—Convulsion—Vincristine—lymphatic system cancer	0.000162	0.000795	CcSEcCtD
Cyclosporine—Hypertension—Vincristine—lymphatic system cancer	0.000162	0.000793	CcSEcCtD
Cyclosporine—Confusional state—Carmustine—lymphatic system cancer	0.000161	0.000791	CcSEcCtD
Cyclosporine—Oedema—Carmustine—lymphatic system cancer	0.00016	0.000785	CcSEcCtD
Cyclosporine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000159	0.000782	CcSEcCtD
Cyclosporine—Myalgia—Vincristine—lymphatic system cancer	0.000159	0.000782	CcSEcCtD
Cyclosporine—Visual disturbance—Methotrexate—lymphatic system cancer	0.000159	0.000781	CcSEcCtD
Cyclosporine—Cough—Mitoxantrone—lymphatic system cancer	0.000159	0.00078	CcSEcCtD
Cyclosporine—Infection—Carmustine—lymphatic system cancer	0.000159	0.00078	CcSEcCtD
Cyclosporine—Vomiting—Fludarabine—lymphatic system cancer	0.000159	0.00078	CcSEcCtD
Cyclosporine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000158	0.000775	CcSEcCtD
Cyclosporine—Rash—Fludarabine—lymphatic system cancer	0.000158	0.000773	CcSEcCtD
Cyclosporine—Dermatitis—Fludarabine—lymphatic system cancer	0.000158	0.000773	CcSEcCtD
Cyclosporine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000157	0.000772	CcSEcCtD
Cyclosporine—Pain—Bleomycin—lymphatic system cancer	0.000157	0.000769	CcSEcCtD
Cyclosporine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000157	0.000769	CcSEcCtD
Cyclosporine—Headache—Fludarabine—lymphatic system cancer	0.000157	0.000768	CcSEcCtD
Cyclosporine—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000156	0.000764	CcSEcCtD
Cyclosporine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000155	0.000761	CcSEcCtD
Cyclosporine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000155	0.000761	CcSEcCtD
Cyclosporine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000155	0.000761	CcSEcCtD
Cyclosporine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000155	0.000759	CcSEcCtD
Cyclosporine—Lethargy—Methotrexate—lymphatic system cancer	0.000154	0.000755	CcSEcCtD
Cyclosporine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000153	0.000752	CcSEcCtD
Cyclosporine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000153	0.000749	CcSEcCtD
Cyclosporine—Oedema—Vincristine—lymphatic system cancer	0.000153	0.000749	CcSEcCtD
Cyclosporine—Anorexia—Carmustine—lymphatic system cancer	0.000153	0.000748	CcSEcCtD
Cyclosporine—Infection—Vincristine—lymphatic system cancer	0.000152	0.000744	CcSEcCtD
Cyclosporine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000151	0.000741	CcSEcCtD
Cyclosporine—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000151	0.00074	CcSEcCtD
Cyclosporine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00015	0.000736	CcSEcCtD
Cyclosporine—Nervous system disorder—Vincristine—lymphatic system cancer	0.00015	0.000735	CcSEcCtD
Cyclosporine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00015	0.000734	CcSEcCtD
Cyclosporine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000149	0.00073	CcSEcCtD
Cyclosporine—Oedema—Mitoxantrone—lymphatic system cancer	0.000149	0.00073	CcSEcCtD
Cyclosporine—Nausea—Fludarabine—lymphatic system cancer	0.000149	0.000729	CcSEcCtD
Cyclosporine—Infection—Mitoxantrone—lymphatic system cancer	0.000148	0.000725	CcSEcCtD
Cyclosporine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000148	0.000724	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000146	0.000715	CcSEcCtD
Cyclosporine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000146	0.000714	CcSEcCtD
Cyclosporine—Urticaria—Bleomycin—lymphatic system cancer	0.000146	0.000714	CcSEcCtD
Cyclosporine—Anorexia—Vincristine—lymphatic system cancer	0.000146	0.000714	CcSEcCtD
Cyclosporine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000145	0.000711	CcSEcCtD
Cyclosporine—Insomnia—Carmustine—lymphatic system cancer	0.000145	0.00071	CcSEcCtD
Cyclosporine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000145	0.000709	CcSEcCtD
Cyclosporine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000144	0.000705	CcSEcCtD
Cyclosporine—Paraesthesia—Carmustine—lymphatic system cancer	0.000144	0.000705	CcSEcCtD
Cyclosporine—Mood swings—Methotrexate—lymphatic system cancer	0.000143	0.000701	CcSEcCtD
Cyclosporine—Dyspnoea—Carmustine—lymphatic system cancer	0.000143	0.0007	CcSEcCtD
Cyclosporine—Somnolence—Carmustine—lymphatic system cancer	0.000142	0.000698	CcSEcCtD
Cyclosporine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000142	0.000696	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000139	0.000683	CcSEcCtD
Cyclosporine—Decreased appetite—Carmustine—lymphatic system cancer	0.000139	0.000682	CcSEcCtD
Cyclosporine—Insomnia—Vincristine—lymphatic system cancer	0.000138	0.000678	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000138	0.000678	CcSEcCtD
Cyclosporine—Paraesthesia—Vincristine—lymphatic system cancer	0.000137	0.000673	CcSEcCtD
Cyclosporine—Pain—Carmustine—lymphatic system cancer	0.000137	0.000671	CcSEcCtD
Cyclosporine—Constipation—Carmustine—lymphatic system cancer	0.000137	0.000671	CcSEcCtD
Cyclosporine—Breast disorder—Methotrexate—lymphatic system cancer	0.000136	0.000668	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000136	0.000665	CcSEcCtD
Cyclosporine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000135	0.000663	CcSEcCtD
Cyclosporine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000134	0.000655	CcSEcCtD
Cyclosporine—Decreased appetite—Vincristine—lymphatic system cancer	0.000133	0.000651	CcSEcCtD
Cyclosporine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000133	0.000651	CcSEcCtD
Cyclosporine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000132	0.000649	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000132	0.000647	CcSEcCtD
Cyclosporine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000132	0.000647	CcSEcCtD
Cyclosporine—Fatigue—Vincristine—lymphatic system cancer	0.000132	0.000646	CcSEcCtD
Cyclosporine—Asthenia—Bleomycin—lymphatic system cancer	0.000132	0.000645	CcSEcCtD
Cyclosporine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000131	0.000642	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000131	0.000642	CcSEcCtD
Cyclosporine—Pain—Vincristine—lymphatic system cancer	0.000131	0.000641	CcSEcCtD
Cyclosporine—Constipation—Vincristine—lymphatic system cancer	0.000131	0.000641	CcSEcCtD
Cyclosporine—Pruritus—Bleomycin—lymphatic system cancer	0.00013	0.000636	CcSEcCtD
Cyclosporine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000129	0.000634	CcSEcCtD
Cyclosporine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000128	0.000629	CcSEcCtD
Cyclosporine—Pancreatitis—Methotrexate—lymphatic system cancer	0.000128	0.000627	CcSEcCtD
Cyclosporine—Pain—Mitoxantrone—lymphatic system cancer	0.000127	0.000624	CcSEcCtD
Cyclosporine—Constipation—Mitoxantrone—lymphatic system cancer	0.000127	0.000624	CcSEcCtD
Cyclosporine—Body temperature increased—Carmustine—lymphatic system cancer	0.000127	0.000621	CcSEcCtD
Cyclosporine—Abdominal pain—Carmustine—lymphatic system cancer	0.000127	0.000621	CcSEcCtD
Cyclosporine—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000125	0.000613	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000125	0.000613	CcSEcCtD
Cyclosporine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000123	0.000601	CcSEcCtD
Cyclosporine—Dysuria—Methotrexate—lymphatic system cancer	0.000122	0.000598	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000122	0.000597	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000121	0.000594	CcSEcCtD
Cyclosporine—Body temperature increased—Vincristine—lymphatic system cancer	0.000121	0.000592	CcSEcCtD
Cyclosporine—Abdominal pain—Vincristine—lymphatic system cancer	0.000121	0.000592	CcSEcCtD
Cyclosporine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000118	0.00058	CcSEcCtD
Cyclosporine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000118	0.000578	CcSEcCtD
Cyclosporine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000118	0.000577	CcSEcCtD
Cyclosporine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000118	0.000577	CcSEcCtD
Cyclosporine—Pneumonia—Methotrexate—lymphatic system cancer	0.000117	0.000573	CcSEcCtD
Cyclosporine—Vomiting—Bleomycin—lymphatic system cancer	0.000117	0.000572	CcSEcCtD
Cyclosporine—Infestation NOS—Methotrexate—lymphatic system cancer	0.000116	0.00057	CcSEcCtD
Cyclosporine—Infestation—Methotrexate—lymphatic system cancer	0.000116	0.00057	CcSEcCtD
Cyclosporine—Depression—Methotrexate—lymphatic system cancer	0.000116	0.000568	CcSEcCtD
Cyclosporine—Rash—Bleomycin—lymphatic system cancer	0.000116	0.000567	CcSEcCtD
Cyclosporine—Dermatitis—Bleomycin—lymphatic system cancer	0.000115	0.000566	CcSEcCtD
Cyclosporine—Asthenia—Carmustine—lymphatic system cancer	0.000115	0.000563	CcSEcCtD
Cyclosporine—Renal failure—Methotrexate—lymphatic system cancer	0.000114	0.00056	CcSEcCtD
Cyclosporine—Stomatitis—Methotrexate—lymphatic system cancer	0.000113	0.000556	CcSEcCtD
Cyclosporine—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000113	0.000554	CcSEcCtD
Cyclosporine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000113	0.000552	CcSEcCtD
Cyclosporine—Haematuria—Methotrexate—lymphatic system cancer	0.000111	0.000544	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00011	0.000539	CcSEcCtD
Cyclosporine—Epistaxis—Methotrexate—lymphatic system cancer	0.00011	0.000538	CcSEcCtD
Cyclosporine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00011	0.000538	CcSEcCtD
Cyclosporine—Asthenia—Vincristine—lymphatic system cancer	0.00011	0.000538	CcSEcCtD
Cyclosporine—Diarrhoea—Carmustine—lymphatic system cancer	0.000109	0.000537	CcSEcCtD
Cyclosporine—Nausea—Bleomycin—lymphatic system cancer	0.000109	0.000534	CcSEcCtD
Cyclosporine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000107	0.000524	CcSEcCtD
Cyclosporine—Dizziness—Carmustine—lymphatic system cancer	0.000106	0.000519	CcSEcCtD
Cyclosporine—Haemoglobin—Methotrexate—lymphatic system cancer	0.000105	0.000514	CcSEcCtD
Cyclosporine—Diarrhoea—Vincristine—lymphatic system cancer	0.000105	0.000513	CcSEcCtD
Cyclosporine—Hepatitis—Methotrexate—lymphatic system cancer	0.000104	0.000512	CcSEcCtD
Cyclosporine—Haemorrhage—Methotrexate—lymphatic system cancer	0.000104	0.000512	CcSEcCtD
Cyclosporine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000104	0.000508	CcSEcCtD
Cyclosporine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000103	0.000505	CcSEcCtD
Cyclosporine—Urethral disorder—Methotrexate—lymphatic system cancer	0.000102	0.000502	CcSEcCtD
Cyclosporine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000102	0.000499	CcSEcCtD
Cyclosporine—Vomiting—Carmustine—lymphatic system cancer	0.000102	0.000499	CcSEcCtD
Cyclosporine—Dizziness—Vincristine—lymphatic system cancer	0.000101	0.000496	CcSEcCtD
Cyclosporine—Rash—Carmustine—lymphatic system cancer	0.000101	0.000495	CcSEcCtD
Cyclosporine—Dermatitis—Carmustine—lymphatic system cancer	0.000101	0.000494	CcSEcCtD
Cyclosporine—Visual impairment—Methotrexate—lymphatic system cancer	0.000101	0.000493	CcSEcCtD
Cyclosporine—Headache—Carmustine—lymphatic system cancer	0.0001	0.000492	CcSEcCtD
Cyclosporine—Tinnitus—Methotrexate—lymphatic system cancer	9.73e-05	0.000477	CcSEcCtD
Cyclosporine—Vomiting—Vincristine—lymphatic system cancer	9.71e-05	0.000476	CcSEcCtD
Cyclosporine—Rash—Vincristine—lymphatic system cancer	9.63e-05	0.000472	CcSEcCtD
Cyclosporine—Dermatitis—Vincristine—lymphatic system cancer	9.62e-05	0.000472	CcSEcCtD
Cyclosporine—Headache—Vincristine—lymphatic system cancer	9.57e-05	0.000469	CcSEcCtD
Cyclosporine—Nausea—Carmustine—lymphatic system cancer	9.51e-05	0.000466	CcSEcCtD
Cyclosporine—Angiopathy—Methotrexate—lymphatic system cancer	9.47e-05	0.000464	CcSEcCtD
Cyclosporine—Vomiting—Mitoxantrone—lymphatic system cancer	9.46e-05	0.000464	CcSEcCtD
Cyclosporine—Mediastinal disorder—Methotrexate—lymphatic system cancer	9.4e-05	0.000461	CcSEcCtD
Cyclosporine—Rash—Mitoxantrone—lymphatic system cancer	9.38e-05	0.00046	CcSEcCtD
Cyclosporine—Dermatitis—Mitoxantrone—lymphatic system cancer	9.37e-05	0.00046	CcSEcCtD
Cyclosporine—Chills—Methotrexate—lymphatic system cancer	9.36e-05	0.000459	CcSEcCtD
Cyclosporine—Headache—Mitoxantrone—lymphatic system cancer	9.32e-05	0.000457	CcSEcCtD
Cyclosporine—Alopecia—Methotrexate—lymphatic system cancer	9.22e-05	0.000452	CcSEcCtD
Cyclosporine—Mental disorder—Methotrexate—lymphatic system cancer	9.14e-05	0.000448	CcSEcCtD
Cyclosporine—Malnutrition—Methotrexate—lymphatic system cancer	9.08e-05	0.000445	CcSEcCtD
Cyclosporine—Nausea—Vincristine—lymphatic system cancer	9.07e-05	0.000445	CcSEcCtD
Cyclosporine—Dysgeusia—Methotrexate—lymphatic system cancer	8.89e-05	0.000436	CcSEcCtD
Cyclosporine—Nausea—Mitoxantrone—lymphatic system cancer	8.84e-05	0.000433	CcSEcCtD
Cyclosporine—Vision blurred—Methotrexate—lymphatic system cancer	8.56e-05	0.00042	CcSEcCtD
Cyclosporine—Ill-defined disorder—Methotrexate—lymphatic system cancer	8.43e-05	0.000413	CcSEcCtD
Cyclosporine—Anaemia—Methotrexate—lymphatic system cancer	8.39e-05	0.000412	CcSEcCtD
Cyclosporine—Malaise—Methotrexate—lymphatic system cancer	8.19e-05	0.000402	CcSEcCtD
Cyclosporine—Vertigo—Methotrexate—lymphatic system cancer	8.16e-05	0.0004	CcSEcCtD
Cyclosporine—Leukopenia—Methotrexate—lymphatic system cancer	8.13e-05	0.000399	CcSEcCtD
Cyclosporine—Cough—Methotrexate—lymphatic system cancer	7.93e-05	0.000389	CcSEcCtD
Cyclosporine—Convulsion—Methotrexate—lymphatic system cancer	7.87e-05	0.000386	CcSEcCtD
Cyclosporine—Chest pain—Methotrexate—lymphatic system cancer	7.73e-05	0.000379	CcSEcCtD
Cyclosporine—Myalgia—Methotrexate—lymphatic system cancer	7.73e-05	0.000379	CcSEcCtD
Cyclosporine—Arthralgia—Methotrexate—lymphatic system cancer	7.73e-05	0.000379	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	7.68e-05	0.000377	CcSEcCtD
Cyclosporine—Discomfort—Methotrexate—lymphatic system cancer	7.64e-05	0.000375	CcSEcCtD
Cyclosporine—Confusional state—Methotrexate—lymphatic system cancer	7.47e-05	0.000367	CcSEcCtD
Cyclosporine—Anaphylactic shock—Methotrexate—lymphatic system cancer	7.41e-05	0.000364	CcSEcCtD
Cyclosporine—Infection—Methotrexate—lymphatic system cancer	7.36e-05	0.000361	CcSEcCtD
Cyclosporine—Nervous system disorder—Methotrexate—lymphatic system cancer	7.27e-05	0.000357	CcSEcCtD
Cyclosporine—Thrombocytopenia—Methotrexate—lymphatic system cancer	7.26e-05	0.000356	CcSEcCtD
Cyclosporine—Skin disorder—Methotrexate—lymphatic system cancer	7.2e-05	0.000353	CcSEcCtD
Cyclosporine—Hyperhidrosis—Methotrexate—lymphatic system cancer	7.17e-05	0.000351	CcSEcCtD
Cyclosporine—Anorexia—Methotrexate—lymphatic system cancer	7.07e-05	0.000347	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	6.75e-05	0.000331	CcSEcCtD
Cyclosporine—Insomnia—Methotrexate—lymphatic system cancer	6.7e-05	0.000329	CcSEcCtD
Cyclosporine—Paraesthesia—Methotrexate—lymphatic system cancer	6.66e-05	0.000326	CcSEcCtD
Cyclosporine—Dyspnoea—Methotrexate—lymphatic system cancer	6.61e-05	0.000324	CcSEcCtD
Cyclosporine—Somnolence—Methotrexate—lymphatic system cancer	6.59e-05	0.000323	CcSEcCtD
Cyclosporine—Dyspepsia—Methotrexate—lymphatic system cancer	6.52e-05	0.00032	CcSEcCtD
Cyclosporine—Decreased appetite—Methotrexate—lymphatic system cancer	6.44e-05	0.000316	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	6.4e-05	0.000314	CcSEcCtD
Cyclosporine—Fatigue—Methotrexate—lymphatic system cancer	6.39e-05	0.000313	CcSEcCtD
Cyclosporine—Pain—Methotrexate—lymphatic system cancer	6.34e-05	0.000311	CcSEcCtD
Cyclosporine—Feeling abnormal—Methotrexate—lymphatic system cancer	6.11e-05	0.0003	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	6.06e-05	0.000297	CcSEcCtD
Cyclosporine—Urticaria—Methotrexate—lymphatic system cancer	5.89e-05	0.000289	CcSEcCtD
Cyclosporine—Abdominal pain—Methotrexate—lymphatic system cancer	5.86e-05	0.000287	CcSEcCtD
Cyclosporine—Body temperature increased—Methotrexate—lymphatic system cancer	5.86e-05	0.000287	CcSEcCtD
Cyclosporine—Hypersensitivity—Methotrexate—lymphatic system cancer	5.46e-05	0.000268	CcSEcCtD
Cyclosporine—Asthenia—Methotrexate—lymphatic system cancer	5.32e-05	0.000261	CcSEcCtD
Cyclosporine—Pruritus—Methotrexate—lymphatic system cancer	5.24e-05	0.000257	CcSEcCtD
Cyclosporine—Diarrhoea—Methotrexate—lymphatic system cancer	5.07e-05	0.000249	CcSEcCtD
Cyclosporine—Dizziness—Methotrexate—lymphatic system cancer	4.9e-05	0.00024	CcSEcCtD
Cyclosporine—Vomiting—Methotrexate—lymphatic system cancer	4.71e-05	0.000231	CcSEcCtD
Cyclosporine—Rash—Methotrexate—lymphatic system cancer	4.67e-05	0.000229	CcSEcCtD
Cyclosporine—Dermatitis—Methotrexate—lymphatic system cancer	4.67e-05	0.000229	CcSEcCtD
Cyclosporine—Headache—Methotrexate—lymphatic system cancer	4.64e-05	0.000228	CcSEcCtD
Cyclosporine—Nausea—Methotrexate—lymphatic system cancer	4.4e-05	0.000216	CcSEcCtD
